Provided by Tiger Trade Technology Pte. Ltd.

Viridian Therapeutics, Inc.

18.34
+0.06000.33%
Volume:2.44M
Turnover:44.32M
Market Cap:2.08B
PE:-5.30
High:18.44
Open:18.02
Low:17.59
Close:18.28
52wk High:34.29
52wk Low:13.18
Shares:113.29M
Float Shares:101.00M
Volume Ratio:1.07
T/O Rate:2.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4579
EPS(LYR):-3.3245
ROE:-65.74%
ROA:-30.16%
PB:3.68
PE(LYR):-5.52

Loading ...

Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Viridian Therapeutics (VRDN)

TIPRANKS
·
Jun 17

Viridian Therapeutics shareholders elected Class II directors at annual meeting

Reuters
·
Jun 03

How Investors May Respond To Viridian Therapeutics (VRDN) Debt Repayment And WuXi Manufacturing Pact

Simply Wall St.
·
May 31

Viridian Therapeutics prepays Hercules loan, repays about $55.1 million

Reuters
·
May 29

Viridian Therapeutics management to present at Jefferies Global Healthcare Conference

Reuters
·
May 27

Viridian Therapeutics signs WuXi Biologics manufacturing pact for veligrotug commercial supply

Reuters
·
May 27

Viridian Therapeutics Inc - WuXi Biologics to Manufacture and Supply Veligrotug for Viridian Therapeutics - SEC Filing

THOMSON REUTERS
·
May 27

Evercore ISI Sticks to Its Buy Rating for Viridian Therapeutics (VRDN)

TIPRANKS
·
May 15

Fairmount Healthcare Fund II buys 1,176,470 Viridian shares for $20 million

Reuters
·
May 14

Viridian prices USD 250 million 1.75% convertible notes due 2032

Reuters
·
May 12

BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise

Reuters
·
May 08

BUZZ-Viridian Therapeutics drops on increased stock, convertible bond offerings

Reuters
·
May 07

Viridian prices upsized USD 225 million 1.75% convertible senior notes due 2032

Reuters
·
May 07

Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock With Aggregate Gross Proceeds of $350.0 Million

THOMSON REUTERS
·
May 07

Stock Track | Viridian Therapeutics Plunges 6.67% in Pre-Market Amid Mounting Losses and Profitability Concerns

Stock Track
·
May 06

Viridian Therapeutics launches USD 150 million convertible senior notes due 2032 offering

Reuters
·
May 06

BUZZ-U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel

Reuters
·
May 06

Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM) and Viridian Therapeutics (VRDN)

TIPRANKS
·
May 06

Analysts Are Bullish on These Healthcare Stocks: Ufp Technologies (UFPT), Viridian Therapeutics (VRDN)

TIPRANKS
·
May 05

Viridian Therapeutics Up Over 24%, on Pace for Largest Percent Increase Since September 2024 -- Data Talk

Dow Jones
·
May 05